Federal disclosures show Donald Trump purchased between $1 million and $5 million of Axon Enterprise stock on February 10, roughly two weeks before U.S. Immigration and Customs Enforcement moved to solicit a five-year, $220 million Taser contract that experts say was effectively written around Axon's product line. The February 24 ICE notice never mentions Axon by name, but its technical requirements—including a 45-foot effective range and 10 individually deployable probes—closely match the TASER 10 model and would effectively exclude any rival bidder, according to procurement reviewers and policing experts. Investigators have found no evidence that Trump influenced the procurement, that officials knew of his shareholding, or that Axon was aware the president owned its stock. The White House stated Trump's assets are held in a trust managed by his children and that investments are handled by independent third-party firms, with a spokesperson saying there are no conflicts of interest. Ethics experts told CNBC the concern centers on the appearance of a conflict, noting that Trump bought into a company whose business could grow if his own administration expands immigration enforcement. Measured from Trump's purchase date through June 26, Axon shares had climbed about 7%, which could translate to a paper profit of roughly $350,000 if he acquired stock near the upper boundary of the reported range. Federal procurement records show no contract has been awarded, and an anonymous source said the contract's cost and recent turnover in DHS leadership have slowed its progress, though the department is not expected to abandon the effort.
Axon Enterprise Inc.ICE solicited a $220M Taser contract effectively written around Axon's product line, boosting potential sales.